DIFFERENCES IN IMMUNE TRANSCRIPTOMIC PROFILE ARE ASSOCIATED WITH RESPONSE TO AZACITIDINE AND VENETOCLAX IN NEWLY DIAGNOSED UNFIT-FOR-CHEMOTHERAPY ACUTE MYELOID LEUKEMIA PATIENTS

被引：0
|
作者：
Zannoni, L. [1 ]
Forte, D. [1 ]
Sartor, C. [1 ]
Cristiano, G. [1 ]
Nanni, J. [1 ]
Parisi, S. [2 ]
Zingarelli, F. [1 ]
Bandini, L. [1 ]
Testoni, N. [1 ]
Ottaviani, E. [2 ]
Paolini, S. [2 ]
Papayannidis, C. [2 ]
Cavo, M. [1 ,3 ]
Rutella, S. [3 ]
Curti, A. [2 ]
机构：
[1] Univ Bologna, Dipartimento Sci Med Chirurg, Bologna, Italy
[2] Univ Bologna, Ist Ematol Seragnoli, IRCCS Azienda Osped, Bologna, Italy
[3] Nottingham Trent Univ, John Geest Canc Res Ctr, Nottingham, England
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P033
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [21] Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study
    Yang, Li
    Chen, Fangli
    Liang, Hong
    Bai, Yunsong
    Wu, Wenzhong
    Yan, Xiaojing
    Ren, Jinhai
    Li, Si
    Yu, Yang
    Tong, Laigen
    Pan, Deng
    Liu, Ligen
    BLOOD, 2023, 142
  • [22] Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry
    Labrador, Jorge
    Martinez-Cuadron, David
    de la Fuente, Adolfo
    Rodriguez-Veiga, Rebeca
    Serrano, Josefina
    Tormo, Mar
    Perez-Simon, Jose Antonio
    Ramos, Fernando
    del Castillo, Teresa Bernal
    Lopez-Pavia, Maria
    Trigo, Fernanda
    Sanchez, Pilar Martinez
    Rodriguez-Gutierrez, Juan Ignacio
    Rodriguez, Carlos
    Gil, Cristina
    Garcia, Daniel
    Vives, Susana
    Foncillas, Maria Angeles
    Encinas, Manuel Perez
    Novo, Andres
    Recio, Isabel
    Rodriguez-Macias, Gabriela
    Burgues, Juan Miguel Bergua
    Concepcion, Victor Noriega
    Lavilla, Esperanza
    Perez, Alicia Roldan
    Sanz, Miguel A.
    Montesinos, Pau
    BLOOD, 2020, 136
  • [23] Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
    Labrador, Jorge
    Martinez-Cuadron, David
    de la Fuente, Adolfo
    Rodriguez-Veiga, Rebeca
    Serrano, Josefina
    Tormo, Mar
    Rodriguez-Arboli, Eduardo
    Ramos, Fernando
    Bernal, Teresa
    Lopez-Pavia, Maria
    Trigo, Fernanda
    Martinez-Sanchez, Maria Pilar
    Rodriguez-Gutierrez, Juan-Ignacio
    Rodriguez-Medina, Carlos
    Gil, Cristina
    Belmonte, Daniel Garcia
    Vives, Susana
    Foncillas, Maria-Angeles
    Perez-Encinas, Manuel
    Novo, Andres
    Recio, Isabel
    Rodriguez-Macias, Gabriela
    Bergua, Juan Miguel
    Noriega, Victor
    Lavilla, Esperanza
    Roldan-Perez, Alicia
    Sanz, Miguel A.
    Montesinos, Pau
    CANCERS, 2022, 14 (09)
  • [24] THE USE OF AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNFIT FOR INTENSIVE TREATMENT OR RESISTANT TO CHEMOTHERAPY
    Alpoim, M.
    Pinto, R.
    Gomes, P.
    Amorim, M.
    Carneiro, A.
    Principe, F.
    Guimaraes, J.
    HAEMATOLOGICA, 2013, 98 : 533 - 534
  • [25] Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III study
    Garcia-Manero, Guillermo
    Kazmierczak, Maciej
    Wierzbowska, Agnieszka
    Fong, Chun Yew
    Keng, Michael K.
    Ballinari, Gianluca
    Scarci, Francesco
    Ades, Lionel
    LEUKEMIA RESEARCH, 2024, 140
  • [26] Cytopenia Management in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Azacitidine in the VIALE-A Study
    Pratz, Keith W.
    DiNardo, Courtney D.
    Selleslag, Dominik
    Li, Junmin
    Yamamoto, Kazuhito
    Konopleva, Marina
    McDonald, Andrew
    Babu, Sunil
    Stevens, Don A.
    Kantarjian, Hagop M.
    Traina, Fabiola
    Venditti, Adriano
    Mayer, Jiri
    Montez, Melissa
    Ramsingh, Giridharan
    Jin, Huan
    Ainsworth, William
    Duan, Yinghui
    Svensson, Anders Erik
    Werner, Michael
    Potluri, Jalaja
    Jonas, Brian A.
    BLOOD, 2020, 136
  • [27] Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients with Acute Myeloid Leukemia and Adverse Risk Features
    Gutman, Jonathan A.
    Winters, Amanda
    Amaya, Maria L.
    McMahon, Christine M.
    Schowinsky, Jeffrey
    Abbott, Diana
    Hammes, Andrew
    Pei, Shanshan
    Stevens, Brett M.
    Jordan, Craig T.
    Smith, Clayton
    Pollyea, Daniel A.
    BLOOD, 2020, 136
  • [28] Bone Marrow Cellularity and Recovery of Blood Counts after Venetoclax and Azacitidine in Elderly Acute Myeloid Leukemia Patients Unfit for Induction Chemotherapy
    Dugan, James
    Pollyea, Daniel A.
    Abbott, Diana
    Schultheiss, Theodore
    BLOOD, 2017, 130
  • [29] Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
    Zhang, Keyuan
    Zhang, Xiang
    Xu, Yang
    Xue, Shengli
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Chen, Suning
    Sun, Aining
    Zhang, Yanming
    Wu, Depei
    Wang, Ying
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [30] Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
    Keyuan Zhang
    Xiang Zhang
    Yang Xu
    Shengli Xue
    Huiying Qiu
    Xiaowen Tang
    Yue Han
    Suning Chen
    Aining Sun
    Yanming Zhang
    Depei Wu
    Ying Wang
    Blood Cancer Journal, 13
12345